When Patients Can't Find Their Birth Control, Providers Can Help

Contraceptive access issues are becoming an increasingly common reason patients contact your office. When a patient calls to say they can't find Aurovela Fe 1/20 at their pharmacy, it often falls to the clinical team to troubleshoot the problem — even though the issue has nothing to do with the drug's safety or efficacy.

This guide provides a practical, step-by-step approach to help your patients find Aurovela Fe 1/20 or a suitable equivalent, with minimal disruption to your workflow.

Current Availability of Aurovela Fe 1/20

Aurovela Fe 1/20 (norethindrone acetate 1 mg/ethinyl estradiol 20 mcg with ferrous fumarate) is manufactured by Aurobindo Pharma and remains in active production. It is not on the FDA Drug Shortage list.

However, availability at the pharmacy counter is inconsistent due to:

• Chain pharmacy formulary changes (CVS, Walgreens, and others have deprioritized Aurovela in some markets)
• Distributor stocking decisions
• Regional supply variations

The drug is generally available through independent pharmacies, mail-order services, and pharmaceutical distributors. For a detailed timeline and background, see our provider briefing on the Aurovela Fe 1/20 shortage.

Why Patients Can't Find It

Understanding why patients encounter availability issues can help you provide better guidance:

Pharmacy-Level Formulary Restrictions

The most common reason is that the patient's pharmacy has stopped stocking Aurovela Fe 1/20 in favor of a different generic (such as Junel Fe 1/20 or Microgestin Fe 1/20). Staff may incorrectly tell patients the drug has been "discontinued."

Prescription Specificity

If the prescription specifies "Aurovela Fe 1/20" by trade name with "dispense as written" or "no substitution," the pharmacist cannot dispense an equivalent generic. This is the most easily fixable cause of fill failures.

Insurance Preferred Drug Lists

Some insurance plans and PBMs have moved Aurovela Fe 1/20 off their preferred drug lists, creating a cost barrier or requiring the pharmacy to stock the preferred alternative instead.

Patient Awareness

Patients may not know they can ask for equivalent generics or that tools exist to check stock at other pharmacies. They may simply assume if their pharmacy doesn't have it, they're out of options.

What Providers Can Do: 5 Practical Steps

Step 1: Write Flexible Prescriptions

The single most impactful thing you can do is write prescriptions using the generic name with substitution permitted:

Norethindrone acetate/ethinyl estradiol 1 mg/20 mcg and ferrous fumarate tablets, 28-day pack. Substitution permitted.

This allows pharmacists to dispense any AB-rated equivalent generic in stock, including Junel Fe 1/20, Microgestin Fe 1/20, Blisovi Fe 1/20, or Larin Fe 1/20.

Step 2: Direct Patients to Medfinder

When patients call about availability issues, direct them (or have your staff direct them) to Medfinder. This free tool lets patients search for pharmacies near them that have Aurovela Fe 1/20 — or equivalent generics — in stock right now.

Consider adding Medfinder to your patient handouts or after-visit summaries for contraceptive prescriptions. Visit medfinder.com/providers to learn about the provider-specific features.

Step 3: Recommend Independent Pharmacies

Independent pharmacies typically have:

• Access to multiple distributors
• No corporate formulary restrictions on which generics to stock
• Willingness to special-order specific products within 1-2 business days
• More personalized patient service

When chain pharmacies can't help, an independent pharmacy is often the fastest solution.

Step 4: Prescribe 90-Day Supplies

Where insurance allows, prescribing 90-day supplies reduces the number of refill events per year from 12 to 4, cutting the chances of encountering a stock-out by two-thirds. This is especially helpful for patients who have experienced repeated fill difficulties.

Step 5: Educate Patients About Generic Equivalence

Take 30 seconds during the prescribing visit to explain:

• Aurovela Fe 1/20, Junel Fe 1/20, Microgestin Fe 1/20, Blisovi Fe 1/20, and Larin Fe 1/20 all contain the exact same hormones at the exact same doses
• The FDA considers them therapeutically equivalent
• Switching between them does not require a washout period or dose adjustment
• Minor differences in inactive ingredients rarely cause noticeable changes

This education empowers patients to accept an available equivalent rather than leaving the pharmacy empty-handed. You can also share our patient-facing article on alternatives to Aurovela Fe 1/20.

Alternatives at a Glance

All of the following are AB-rated therapeutically equivalent generics of Loestrin Fe 1/20:

• Junel Fe 1/20 — Teva Pharmaceuticals — widely available at most chain pharmacies
• Microgestin Fe 1/20 — Mayne Pharma — strong availability, long market history
• Blisovi Fe 1/20 — Lupin Pharmaceuticals — increasingly available
• Larin Fe 1/20 — Novitium Pharma — available through most distributors
• Gildess Fe 1/20 — Teva Pharmaceuticals — another option in the same family

For patients who need a different formulation or have not tolerated norethindrone acetate/ethinyl estradiol, consider:

• Lo Loestrin Fe — lower estrogen dose (10 mcg ethinyl estradiol for 24 days + 10 mcg for 2 days)
• Different progestin pills — levonorgestrel/ethinyl estradiol combinations (e.g., Levlen, Seasonique)
• Non-oral contraceptives — NuvaRing, Xulane patch, hormonal IUDs

Workflow Tips for Your Practice

To handle Aurovela Fe 1/20 fill failures efficiently:

1. Create a protocol: Develop a standard response for staff to follow when patients call about contraceptive availability. Include the Medfinder link, a list of equivalent generics, and instructions for when to escalate to the prescriber.
2. Template your prescriptions: Set up your EHR to default to generic name prescriptions with substitution permitted for oral contraceptives.
3. Batch prior auth requests: If a patient's insurance requires a specific generic, have your prior auth team handle the request proactively rather than reactively.
4. Track patterns: If multiple patients report difficulty with the same pharmacy or the same generic, consider adjusting your default prescribing to favor more available options.
5. Share resources: Include links to patient-facing articles — like those on finding Aurovela Fe 1/20 in stock and saving money on prescriptions — in your after-visit summaries.

Final Thoughts

Aurovela Fe 1/20 availability challenges are a distribution issue, not a clinical one. The drug remains safe, effective, and manufactured. By writing flexible prescriptions, educating patients about generic equivalence, and using tools like Medfinder, providers can help ensure contraceptive continuity for their patients with minimal added burden on the practice.

For a broader look at the Aurovela Fe 1/20 availability timeline and factors, see our 2026 provider shortage briefing.